Please assess the completion status of the following clinical trial:

Trial Title: A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~Aged ≥ 3 months at the screening visit to \< 24 months on baseline/Day 1, diagnosed with AD~Exclusion Criteria:~Subjects with any clinically significant dermatological condition or disease (including active or potentially recurrent non-AD dermatological conditions that overlap with AD such as Netherton Syndrome)

- Gender: ALL
- Minimum Age: 3 Months
- Maximum Age: 23 Months
- Healthy Volunteers: f

Study Arms:
- Crisaborole ointment 2% (Type: EXPERIMENTAL): Subjects will be dosed for 28 days. A thin layer of ointment will be applied to all areas designated for treatment.

Based on this trial design, predict the completion outcome and termination type (if applicable).